Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Citi
Boehringer Ingelheim
Fuji
AstraZeneca
Federal Trade Commission
Cantor Fitzgerald
UBS
US Department of Justice
McKinsey

Generated: February 21, 2018

DrugPatentWatch Database Preview

PROPHENE 65 Drug Profile

« Back to Dashboard

Which patents cover Prophene 65, and when can generic versions of Prophene 65 launch?

Prophene 65 is a drug marketed by Halsey and is included in one NDA.

The generic ingredient in PROPHENE 65 is propoxyphene hydrochloride. There are twenty-seven drug master file entries for this compound. Additional details are available on the propoxyphene hydrochloride profile page.

US Patents and Regulatory Information for PROPHENE 65

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Halsey PROPHENE 65 propoxyphene hydrochloride CAPSULE;ORAL 083538-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chubb
Julphar
Boehringer Ingelheim
Daiichi Sankyo
Argus Health
McKinsey
Colorcon
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot